Matthew Goldberg, Ph.D., joined the UAB Center for Neurodegeneration and Experimental Therapeutics (CNET) as an Associate Professor in September 2014. He was previously a principle investigator at UT Southwestern Medical Center in Dallas, Texas. Dr. Goldberg graduated with a B.S. in physics from the University of Michigan and he earned his Ph.D. in molecular biophysics and biochemistry from Yale University. He received his postdoctoral training in neurodegenerative diseases at Harvard Medical School and Brigham and Women's Hospital in Boston.
Dr. Goldberg's research is focused on identifying the mechanisms of neuronal degeneration in Parkinson's disease and investigating the roles of mitochondrial dysfunction, oxidative stress and genetic mutations in Parkin, DJ-1, PINK1, alpha-synuclein and LRRK2 that cause inherited forms of Parkinson’s disease. Learn more about Dr. Goldberg's research >>
Michelle Gray, Ph.D., joined the UAB Center for Neurodegeneration and Experimental Therapeutics (CNET) in September 2008 as an Instructor of Neurology and Dixon Scholar in Neuroscience and is currently an Assistant Professor. Dr. Gray received her Ph.D. in Molecular, Cellular and Developmental Biology from The Ohio State University in 2003 and served as a postdoctoral fellow in the Semel Institute of Neuroscience and Behavior at the University of California, Los Angeles
Dr. Gray's research interests in neurodegenerative disorders are focused on Huntington's disease, a rare and fatal genetic degenerative disorder. Learn more about Dr. Gray's research >>
Jeremy Herskowitz, Ph.D., Dr. Herskowitz received his B.S. in Chemistry from the University of North Carolina at Chapel Hill in 2001. He earned a Ph.D in Microbiology at Emory University, where he studied mechanisms of gammaherpesvirus pathogenesis in the laboratory of Dr. Samuel Speck. He remained at Emory University for postdoctoral studies and conducted basic research in the laboratory of Drs. James Lah and Allan Levey at the Center for Neurodegenerative Disease, investigating cellular and animal models of Alzheimer’s disease. He was appointed as an Instructor of Neurology at Emory University in 2012. In 2014, he moved to UAB where he is now Assistant Professor of Neurology and Neurobiology and the Collat Scholar in Neuroscience.
Dr. Herskowitz's research interests in neurodegenerative disorders are focused on Alzheimer's disease and the development of novel therapeutic strategies to delay or prevent disease onset. Learn more about Dr. Herskowitz's research >>
Peter King, M.D., Dr. King graduated from Duke University with a BA in zoology in 1981 and Duke University Medical School in 1985. He did a one year research fellowship in Dr. James McNamara’s laboratory in epilepsy research in 1984. His medical training included an internship (internal medicine) at Case Western Reserve University (1985-1986) and a residency in Neurology at Duke University (1987-1990). He completed a molecular biology fellowship in Dr. Jack Keene’s laboratory (1990-1991) studying basic RNA biology and a clinical neuromuscular fellowship at the Cleveland Clinic (1991-1992). He became Assistant Professor of Neurology in 1992 and Assistant Professor of Physiology and Biophysics in 1994. He was later promoted to Associate Professor (1998). He was appointed Chief of Neurology at the Birmingham Veterans Administration Medical Center in 2000.
Dr. King's research interests in neurodegenerative disorders are focused on mechanisms of growth factor mRNA stabilization in malignant gliomas and amyotrophic lateral sclerosis (ALS).
Liang Lu, M.D, Ph.D., Dr. Lu joined the department of Neurology in July of 2004 as an Assistant Professor. Dr. Lu received his Bachelor of Medicine degree from Shanghai Medical University. He also completed an M.D./Ph.D at the Shanghai Institute of Neurology, a WHO collaborating center for research and training in neuroscience. Dr. Lu then came to the United States in 1996 and in 1998 obtained a M.A. degree in Biological Science from the University of Missouri-Columbia. As a physician-scientist, Dr.Lu is involved in a continuum of efforts from laboratory bench to patient bedside. His goal is to provide patients with compassionate and effective care, and the dynamic translational medicine.
Dr. Lu's research interests in neurodegenerative disorders are focused on the role of network RNA-binding proteins in ALS pathogenesis Learn more about Dr. Lu's research >>
Erik Roberson, M.D., Ph.D. is the Co-Director of the UAB Center for Neurodegeneration and Experimental Therapeutics (CNET) and holds a secondary appointment in the Department of Neurobiology. Dr. Roberson joined UAB in August, 2008 as the Virginia B. Spencer Scholar in Neuroscience.
Dr. Roberson’s primary interest is age-related memory disorders and neurodegenerative disease. Learn more about Dr. Roberson's research >>
David Standaert, M.D., Ph.D., is the John N. Whitaker Professor and Chair of the Department of Neurolgoy and is former director and current member of the UAB Center for Neurodegeneration and Experimental Therapeutics (CNET). He is also the director of the Division of Movement Disorders.
Dr. Standaert's lab is interested in the pharmacology and neurochemistry of the basal ganglia and the mechanisms of Parkinson's disease and other conditions which produce abnormalities of movement. Learn more about Dr. Standaert's research >>
Laura Volpicelli-Daley, Ph.D., joined the Center for Neurodegeneration and Experimental Therapeutics at UAB in 2013. She was previously a Senior Research Investigator in the laboratory of Virginia Lee, MBA, PhD, and John Trojanowski, MD, PhD in the Center for Neurodegenerative Disease at the University of Pennsylvania. She performed a postdoctoral fellowship in the Cell Biology department at Yale University in the laboratory of Pietro De Camilli, MD, Howard Hughes Investigator and Co-Director of the Center for Neuroscience, Neurodegeneration and Repair. Here, she studied the role of lipid metabolism in neuronal function. She also received postdoctoral training in the laboratory of Richard Kahn, PhD, Professor of Biochemistry at Emory University, studying the role of ARF small GTPases in membrane traffic. In graduate school at Emory University, she studied the cell biology of muscarinic acetylcholine receptors in the laboratory of Allan Levey, MD, PhD, Chairman of the Neurology department and director of the Alzheimer's disease Center.
Dr. Volpicelli-Daley’s goals are to determine how α-synuclein pathology found in Parkinson’s disease and Dementia with Lewy Bodies impacts membrane traffic in neurons. She also is determining how genes implicated in Parkinson’s Disease impact α-synuclein pathology. Learn more about Dr. Volpicelli-Daley's research >>
Andrew West, Ph.D., is Co-Director of the UAB Center for Neurodegeneration and Experimental Therapeutics (CNET). He joined the Department of Neurology in September of 2007 as an Assistant Professor and the John A. & Ruth R. Jurenko Research Scholar. Dr. West received his undergraduate degree from Alma College and his PhD in Molecular Neuroscience from the Mayo Clinic School of Medicine in Rochester, MN. He then went on to complete a Postdoctoral Fellowship at UCLA Neuropsychiatric Institute in Los Angeles in the laboratory of Nigel Maidment and a second postdoctoral fellowship in the laboratory of Ted Dawson at Johns Hopkins. Dr. West is a recipient of an NIH/NINDS Pathway to Independence (PI) Award K99/R00.
The West Lab focuses on discovering the biochemical and genetic basis of neurological disorders such as Parkinson’s disease and autism spectrum disorders. Learn more about Dr. West's research >>
Talene Yacoubian, M.D., Ph.D., joined the department of Neurology in July of 2006, and is currently an Assistant Professor. Dr Yacoubian received her undergraduate degree from Harvard University, and her MD/PhD from Duke University in 2001. She completed a one year internship at Brigham & Women’s Hospital, Boston and a 3 year Residency in neurology at Massachusetts General Hospital/Brigham & Women’s Hospital. She finished a two year Fellowship in Movement Disorders in July of 2007. Dr. Yacoubian is a 2007 recipient of the American Parkinson Disease Association’s George C. Cotzias, MD Memorial Fellowship.
The Yacoubian Lab is focused on understanding the pathophysiology of Parkinson’s disease with the long-term goal of developing neuroprotective therapies. Learn more about Dr. Yacoubian's research >>